Maslenitsa festival: a week of pancakes and joySociety & Culture February 22, 17:49
Kremlin aide praises late UN envoy as ‘generation’s best and brightest’ diplomatRussian Politics & Diplomacy February 22, 17:28
Russian only Polar Circle city vows to preserve Arctic environmentBusiness & Economy February 22, 17:20
Russian presidential aide says Astana platform helpful for settling Syrian crisisRussian Politics & Diplomacy February 22, 16:55
UN high commissioner urges Europe’s ‘cooperative approach’ to migration situationWorld February 22, 16:51
Russia's defense chief to mobilize new cyber armyMilitary & Defense February 22, 16:49
Presidential aide says all Kremlin’s contacts with Trump administration already reportedRussian Politics & Diplomacy February 22, 16:36
Defense chief praises Russian military's success in SyriaMilitary & Defense February 22, 16:32
Nord Stream 2 secures necessary capacity in offshore pipelay marketBusiness & Economy February 22, 16:09
GENEVA, October 2. /TASS/. The World Health Organization (WHO) on Wednesday published new data, in line with which the death toll from the Ebola virus outbreak has reached 3,338 people out of a total of 7,178 officially registered cases.
The WHO report says the epidemic spread has slowed down for a second week. At the same time, the global health body warned that some cases could be underreported. The figures are cited as of the end of last week, September 28.
The Ebola virus disease (EVD), previously known as the Ebola hemorrhagic fever, is a severe illness in humans, often fatal, according to the WHO website. The virus is passed on to people from wild animals and can be transmitted from humans to humans. The average EVD case death rate is some 50%
The first outbreaks of the EVD occurred in remote Central African villages, near tropical rainforests. However, major urban and rural areas have been involved in the most recent outbreak in western Africa.
Early supportive care, which includes rehydration and symptomatic treatment, improves the survival rate. No licensed treatment has yet been proven to be able to neutralize the virus but a number of blood, immunological and drug medications are under development. There are no licensed Ebola vaccines yet but two candidates are being evaluated.